Combinations of 5-FU, hypoxanthine, and allopurinol in chemotherapy for human colon adenocarcinoma xenografts

J. A. Houghton, Peter J Houghton

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A series of four human colon adenocarcinomas, growing as xenografts in immune-deprived mice, have been used to evaluate the efficacy of 5-FU in combination with two purines, hypoxanthine (Hx) and allopurinol (HPP), which have reduced the toxicity of 5-FU in host mice. Tumor-bearing mice were treated at 7-day intervals with 5-FU administered simultaneously with the protecting agents (Hx and HPP). Two tumor lines (HxVRC5 and HxGC3), insensitive to 5-FU alone, failed to show any response to this combination. In 5-FU-sensitive HxELC2 tumors, the combination of 5-FU with Hx and HPP did not increase the therapeutic index, and in HxHC1 xenografts, antagonism to 5-FU cytotoxicity was observed. Tumor response in relation to the pathways of 5-FU metabolism is discussed.

Original languageEnglish (US)
Pages (from-to)1201-1206
Number of pages6
JournalCancer Treatment Reports
Volume66
Issue number5
StatePublished - Jan 1 1982
Externally publishedYes

Fingerprint

Allopurinol
Hypoxanthine
Heterografts
Fluorouracil
Colon
Adenocarcinoma
Drug Therapy
Neoplasms
Purines

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Combinations of 5-FU, hypoxanthine, and allopurinol in chemotherapy for human colon adenocarcinoma xenografts. / Houghton, J. A.; Houghton, Peter J.

In: Cancer Treatment Reports, Vol. 66, No. 5, 01.01.1982, p. 1201-1206.

Research output: Contribution to journalArticle

@article{0012385910274be6b2bd3340f326473d,
title = "Combinations of 5-FU, hypoxanthine, and allopurinol in chemotherapy for human colon adenocarcinoma xenografts",
abstract = "A series of four human colon adenocarcinomas, growing as xenografts in immune-deprived mice, have been used to evaluate the efficacy of 5-FU in combination with two purines, hypoxanthine (Hx) and allopurinol (HPP), which have reduced the toxicity of 5-FU in host mice. Tumor-bearing mice were treated at 7-day intervals with 5-FU administered simultaneously with the protecting agents (Hx and HPP). Two tumor lines (HxVRC5 and HxGC3), insensitive to 5-FU alone, failed to show any response to this combination. In 5-FU-sensitive HxELC2 tumors, the combination of 5-FU with Hx and HPP did not increase the therapeutic index, and in HxHC1 xenografts, antagonism to 5-FU cytotoxicity was observed. Tumor response in relation to the pathways of 5-FU metabolism is discussed.",
author = "Houghton, {J. A.} and Houghton, {Peter J}",
year = "1982",
month = "1",
day = "1",
language = "English (US)",
volume = "66",
pages = "1201--1206",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Combinations of 5-FU, hypoxanthine, and allopurinol in chemotherapy for human colon adenocarcinoma xenografts

AU - Houghton, J. A.

AU - Houghton, Peter J

PY - 1982/1/1

Y1 - 1982/1/1

N2 - A series of four human colon adenocarcinomas, growing as xenografts in immune-deprived mice, have been used to evaluate the efficacy of 5-FU in combination with two purines, hypoxanthine (Hx) and allopurinol (HPP), which have reduced the toxicity of 5-FU in host mice. Tumor-bearing mice were treated at 7-day intervals with 5-FU administered simultaneously with the protecting agents (Hx and HPP). Two tumor lines (HxVRC5 and HxGC3), insensitive to 5-FU alone, failed to show any response to this combination. In 5-FU-sensitive HxELC2 tumors, the combination of 5-FU with Hx and HPP did not increase the therapeutic index, and in HxHC1 xenografts, antagonism to 5-FU cytotoxicity was observed. Tumor response in relation to the pathways of 5-FU metabolism is discussed.

AB - A series of four human colon adenocarcinomas, growing as xenografts in immune-deprived mice, have been used to evaluate the efficacy of 5-FU in combination with two purines, hypoxanthine (Hx) and allopurinol (HPP), which have reduced the toxicity of 5-FU in host mice. Tumor-bearing mice were treated at 7-day intervals with 5-FU administered simultaneously with the protecting agents (Hx and HPP). Two tumor lines (HxVRC5 and HxGC3), insensitive to 5-FU alone, failed to show any response to this combination. In 5-FU-sensitive HxELC2 tumors, the combination of 5-FU with Hx and HPP did not increase the therapeutic index, and in HxHC1 xenografts, antagonism to 5-FU cytotoxicity was observed. Tumor response in relation to the pathways of 5-FU metabolism is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0019967231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019967231&partnerID=8YFLogxK

M3 - Article

C2 - 7083222

AN - SCOPUS:0019967231

VL - 66

SP - 1201

EP - 1206

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 5

ER -